Insiders who reported open-market trades in the last 12 months at the companies Badreddin Edris files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Alan J. Russell - $10.25M in EWTX purchases and sales in the last 12 months
Joanne M. Donovan - $4.62M in EWTX purchases and sales in the last 12 months
Kevin Koch - $785K in EWTX purchases and sales in the last 12 months
Behrad Derakhshan - $223K in EWTX purchases and sales in the last 12 months
John R. Moore - $220K in EWTX purchases and sales in the last 12 months
Jonathan C. Fox - $199K in EWTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Badreddin Edris is a corporate insider of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Badreddin Edris last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 4 filings going back to 2024.
Has Badreddin Edris been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($4.24M) across all tracked filings.
Badreddin Edris files SEC Form 4 reports at Edgewise Therapeutics, Inc. (EWTX). 4 SEC Form 4 filings on record going back to 2024, most recently on 16 June 2026. Most recent open-market trade: sold $1.96M of EWTX on 23 January 2026. Lifetime open-market sales: $4.24M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Badreddin Edris.
InsiderAlpha's records for Badreddin Edris go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. 17 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
